LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target […]
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) insider Warren Gouk sold 2,858 shares of the business’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $8.51, for a total value of $24,321.58. Following the sale, the insider now directly owns 6,019,108 shares of the company’s stock, […]
Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) have earned a consensus rating of “Moderate Buy” from the six research firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) – Analysts at William Blair boosted their Q2 2023 EPS estimates for LifeStance Health Group in a note issued to investors on Wednesday, May 10th. William Blair analyst R. Daniels now anticipates that the company will earn ($0.10) per share for the quarter, up from their prior […]
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 7,740,000 shares, an increase of 11.8% from the March 31st total of 6,920,000 shares. Based on an average daily volume of 607,200 shares, the short-interest ratio […]